JP2022525318A5 - - Google Patents

Info

Publication number
JP2022525318A5
JP2022525318A5 JP2021555228A JP2021555228A JP2022525318A5 JP 2022525318 A5 JP2022525318 A5 JP 2022525318A5 JP 2021555228 A JP2021555228 A JP 2021555228A JP 2021555228 A JP2021555228 A JP 2021555228A JP 2022525318 A5 JP2022525318 A5 JP 2022525318A5
Authority
JP
Japan
Application number
JP2021555228A
Other languages
Japanese (ja)
Other versions
JP7602803B2 (ja
JP2022525318A (ja
JPWO2020190483A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/020436 external-priority patent/WO2020190483A1/en
Publication of JP2022525318A publication Critical patent/JP2022525318A/ja
Publication of JP2022525318A5 publication Critical patent/JP2022525318A5/ja
Publication of JPWO2020190483A5 publication Critical patent/JPWO2020190483A5/ja
Priority to JP2024194375A priority Critical patent/JP2025013530A/ja
Application granted granted Critical
Publication of JP7602803B2 publication Critical patent/JP7602803B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021555228A 2019-03-15 2020-02-28 Cd147キメラ抗原受容体および使用の方法 Active JP7602803B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024194375A JP2025013530A (ja) 2019-03-15 2024-11-06 Cd147キメラ抗原受容体および使用の方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962819403P 2019-03-15 2019-03-15
US62/819,403 2019-03-15
PCT/US2020/020436 WO2020190483A1 (en) 2019-03-15 2020-02-28 Cd147 chimeric antigen receptors and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024194375A Division JP2025013530A (ja) 2019-03-15 2024-11-06 Cd147キメラ抗原受容体および使用の方法

Publications (4)

Publication Number Publication Date
JP2022525318A JP2022525318A (ja) 2022-05-12
JP2022525318A5 true JP2022525318A5 (https=) 2023-02-24
JPWO2020190483A5 JPWO2020190483A5 (https=) 2023-02-24
JP7602803B2 JP7602803B2 (ja) 2024-12-19

Family

ID=72520374

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021555228A Active JP7602803B2 (ja) 2019-03-15 2020-02-28 Cd147キメラ抗原受容体および使用の方法
JP2024194375A Withdrawn JP2025013530A (ja) 2019-03-15 2024-11-06 Cd147キメラ抗原受容体および使用の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024194375A Withdrawn JP2025013530A (ja) 2019-03-15 2024-11-06 Cd147キメラ抗原受容体および使用の方法

Country Status (6)

Country Link
US (1) US20220152106A1 (https=)
EP (1) EP3938402A4 (https=)
JP (2) JP7602803B2 (https=)
CN (1) CN113853390B (https=)
CA (1) CA3132458A1 (https=)
WO (1) WO2020190483A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021396332A1 (en) * 2020-12-11 2023-06-22 Purdue Research Foundation Human chimeric antigen receptor neutrophils, compositions, kits and methods of use
WO2022138282A1 (ja) * 2020-12-22 2022-06-30 荒木技研工業株式会社 金属管の分岐部構造製造装置及び金属管の分岐部構造の製造方法
WO2023147019A2 (en) * 2022-01-28 2023-08-03 A2 Biotherapeutics, Inc. Compositions and methods for treating mesothelin positive cancers
WO2024220483A2 (en) * 2023-04-19 2024-10-24 Rutgers, The State University Of New Jersey Grp78 chimeric antigen receptors and combination therapies for treating cancer
WO2025105442A1 (ja) * 2023-11-15 2025-05-22 大塚製薬株式会社 キメラ抗原受容体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003828A1 (en) * 1993-08-02 1995-02-09 Houston Biotechnology Incorporated Single-chain immunotoxin compositions and methods for preventing secondary cataracts
AU2009296937B2 (en) * 2008-09-29 2015-02-12 Centocor Ortho Biotech Inc. Anti-CD147 antibodies, methods, and uses
ES2869972T3 (es) * 2015-01-26 2021-10-26 Cellectis Sistemas de receptores de antígenos quiméricos dirigidos por mAb para clasificar/agotar células inmunitarias genomanipuladas
WO2016210447A1 (en) * 2015-06-26 2016-12-29 University Of Southern California Masking chimeric antigen receptor t cells for tumor-specific activation
US20200231652A1 (en) * 2015-08-31 2020-07-23 National Research Council Of Canada Tgf-b-receptor ectodomain fusion molecules and uses thereof
WO2018165619A1 (en) * 2017-03-09 2018-09-13 Cytomx Therapeutics, Inc. Cd147 antibodies, activatable cd147 antibodies, and methods of making and use thereof

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
JP2022525318A5 (https=)
BR112021017747A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016176A2 (https=)